Cargando…
5-HT(1A) receptor activation improves anti-cataleptic effects of levodopa in 6-hydroxydopamine-lesioned rats
BACKGROUND AND THE PURPOSE OF THE STUDY: In Parkinson›s disease (PD) prolong use of L-DOPA causes some motor disorders such as wearing-off and L-DOPA induced dyskinesia (LID). In this investigation the effect of 8-OHDAPT, as a 5-HT(1A) agonist on anti-cataleptic effect of L-DOPA in 6-hydroxydopamine...
Autores principales: | Mahmoudi, J., Mohajjel Nayebi, A., Samini, M., Reyhani-Rad, S., Babapour, V. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Tehran University of Medical Sciences
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3304392/ https://www.ncbi.nlm.nih.gov/pubmed/22615679 |
Ejemplares similares
-
Role of 5-Hydroxytryptamine 1A Receptors in 6-Hydroxydopmaine-induced Catalepsy-like Immobilization in Rats: a Therapeutic Approach for Treating Catalepsy of Parkinson’s Disease
por: eyhani-rad, Siamak, et al.
Publicado: (2012) -
Effect of WR-1065 on 6-hydroxydopamine-induced catalepsy and IL-6 level in rats
por: Kheradmand, Afshin, et al.
Publicado: (2016) -
Cataleptic Hysteria
Publicado: (1856) -
8-OH-DPAT (5-HT1A agonist) Attenuates 6-Hydroxy- dopamine-induced catalepsy and Modulates Inflammatory Cytokines in Rats
por: Sharifi, Hamdolah, et al.
Publicado: (2013) -
Interactions of CaMKII with dopamine D2 receptors: roles in levodopa-induced dyskinesia in 6-hydroxydopamine lesioned Parkinson's rats
por: Zhang, SuFang, et al.
Publicado: (2014)